USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/28532
Title: Critical decisions in coronary interventions: bypass vs. stent - a detailed analysis
Authors: Coicoiu Vlad
Issue Date: 2024
Publisher: Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova
Citation: Coicoiu Vlad. Critical decisions in coronary interventions: bypass vs. stent - a detailed analysis. In: Abstract Book. MedEspera 2024. The 10th International Medical Congress for Students and Young Doctors. 24-27 April 2024, Chișinău, Republic of Moldova, p. 110. ISBN 978-9975-3544-2-4.
Abstract: Introduction. In the context of cardiovascular interventions, coronary artery bypass grafting (CABG) and coronary stenting represent distinct approaches to address coronary artery disease and the choice between them represents a pivotal decision that significantly impacts patient outcomes. CABG involves the surgical rerouting of blood flow around blocked coronary arteries using grafts, typically harvested from the patient's own vessels. On the other hand, coronary stenting is a percutaneous procedure where a stent, a small metal mesh tube, is inserted to prop open narrowed arteries, restoring blood flow. Aim of study. The research was conducted on Web of Science using the keywords "coronary stent," "CABG," "coronary bypass" and "percutaneous coronary intervention." Methods and materials. Scientific papers were selected based on inclusion criteria, which involved patient groups treated with both CABG and coronary stent, hospitalization period, inhospital mortality, bleeding events , stroke , postoperative delirium, the well-being of patients and procedure effectiveness. Articles mentioning patients with major comorbidities , NSTEMI , angina pectoris and any other cardiac surgical intervention ongoing during the same period of hospitalization were excluded. Risk of bias was not assessed, and PRISMA criteria were used for data synthesis. Out of the total of 16 articles found, 6 studies with 5 between 2005 and 2007, and the sixth conducted in 2018 were selected. Results. The cohort comprised 12038 patients, with 2215 treated using CABG and 9823 through percutaneous coronary intervention. The patient group treated with CABG had a hospitalization period of 13.04+- 9.26 days, while the group treated with PCI had a hospitalization period of 5.71 +- 7.60 days. In the CABG-treated patient group, 52 out of 2215 (2.34%) patients died, while in the PCI-treated group, 251 out of 9823 (2.55%) patients succumbed. In the CABG-treated group of 2,215 patients, 30 experienced a stroke (1.35%), compared to 45 strokes among the 9,823 patients treated with stents (0.45%). Conclusion. In conclusion, the comparative analysis of Coronary Artery Bypass Grafting (CABG) and Percutaneous Coronary Intervention (PCI) suggests nuanced considerations. Both interventions demonstrate similar mortality rates. The decision between these procedures should be meticulously tailored to individual patient characteristics, considering factors like lesion complexity, and long-term outcomes. A comprehensive evaluation, weighing the advantages and disadvantages of CABG versus PCI, remains crucial in optimizing cardiovascular care." (CABG) and coronary stenting represent distinct approaches to address coronary artery disease and the choice between them represents a pivotal decisi on that significantly impacts patient outcomes. CABG involves the surgical rerouting of blood flo w around blocked coronary arteries using grafts, typically harvested from the patient's own ve ssels. On the other hand, coronary stenting is a percutaneous procedure where a stent, a small metal mesh tube, is inserted to prop open narrowed arteries, restoring blood flow. Aim of study. The research was conducted on Web of Science using the key words "coronary stent," "CABG," "coronary bypass" and "percutaneous corona ry intervention." Methods and materials. Scientific papers were selected based on inclusion crite ria, which involved patient groups treated with both CABG and coronary sten t, hospitalization period, inhospital mortality, bleeding events, stroke, postoperat ive delirium, the well-being of patients and procedure effectiveness. Articles mentioning patients with m ajor comorbidities, NSTEMI, angina pectoris and any other cardiac surgical intervention ongoin g during the same period of hospitalization were excluded. Risk of bias was not asses sed, and PRISMA criteria were used for data synthesis. Out of the total of 16 articles found, 6 st udies with 5 between 2005 and 2007, and the sixth conducted in 2018 were selected. Results. The cohort comprised 12038 patients, with 2215 treated using CABG an d 9823 through percutaneous coronary intervention. The patient group tr eated with CABG had a hospitalization period of 13.04+- 9.26 days, while the group treated with PCI had a hospitalization period of 5.71 +- 7.60 days. In the CABG-treated patient group, 52 out of 2215 (2.34%) patients died, while in the PCI-treated group, 251 out of 9823 (2.55%) patients succumbed. In the CABG-treated group of 2,215 patients, 30 experienced a stroke (1.35%), compared to 45 strokes among the 9,823 patients treated with stents (0.45%). Conclusion. In conclusion, the comparative analysis of Coronary Art ery Bypass Grafting (CABG) and Percutaneous Coronary Intervention (PCI) suggests nuan ced considerations. Both interventions demonstrate similar mortality rates. Th e decision between these procedures should be meticulously tailored to individual patient characteris tics, considering factors like lesion complexity, and long-term outcomes. A comprehensive eval uation, weighing the advantages and disadvantages of CABG versus PCI, remains crucial in optimiz ing cardiovascular care."
metadata.dc.relation.ispartof: MedEspera 2024
URI: https://ibn.idsi.md/collection_view/3104
http://repository.usmf.md/handle/20.500.12710/28532
ISBN: 978-9975-3544-2-4
Appears in Collections:MedEspera 2024

Files in This Item:
File Description SizeFormat 
MEsp24_110.pdf333.41 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback